• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Trelegy Ellipta

Marketing

AbbVie continues top TV drug ad spender reign

AbbVie’s autoimmune JAK inhibitor Rinvoq topped the TV drug ad spending list for the third month in a row.
Ben Adams Oct 10, 2022 10:57am

GSK, E&I report finds dissatisfaction with asthma management

Sep 9, 2022 7:30am

AstraZeneca's Breztri puts a '60s spin on an animated theme

Feb 28, 2022 8:25am

COVID-19 antibody delivers for GSK amid Nucala, Trelegy landmark

Feb 9, 2022 12:01pm

Japan sees 'drug lag' amid price pressure, industry group warns

Nov 19, 2021 10:46am

Don't wait for Shingrix rebound this year, says GSK

Oct 27, 2021 11:47am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy